93 7236 (Ondansetron Hydrochloride 8 mg)
Pill with imprint 93 7236 is Yellow, Round and has been identified as Ondansetron Hydrochloride 8 mg. It is supplied by Teva Pharmaceuticals USA.
Ondansetron is used in the treatment of nausea/vomiting; nausea/vomiting, chemotherapy induced; nausea/vomiting, postoperative; nausea/vomiting, radiation induced and belongs to the drug class 5HT3 receptor antagonists. There is no proven risk in humans during pregnancy. Ondansetron 8 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for 93 7236
Ondansetron Hydrochloride
- Imprint
- 93 7236
- Strength
- 8 mg
- Color
- Yellow
- Size
- 9.00 mm
- Shape
- Round
- Availability
- Prescription only
- Drug Class
- 5ht3 receptor antagonists
- Pregnancy Category
- B - No proven risk in humans
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Teva Pharmaceuticals USA
- Inactive Ingredients
-
hypromellose 2910 (5 mPa.s),
lactose monohydrate,
magnesium stearate,
microcrystalline cellulose,
corn starch,
polyethylene glycol 6000,
polyethylene glycol 400,
sodium starch glycolate type A potato,
titanium dioxide,
ferric oxide yellow
Note: Inactive ingredients may vary.
Labelers / Repackagers
| NDC Code | Labeler / Repackager |
|---|---|
| 00093-7236 (Discontinued) | Teva Pharmaceuticals USA, Inc. |
| 35356-0445 | Lake Erie Medical and Surgical Supply (repackager) |
Related Images for "93 7236"
More about ondansetron
- Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Patient Tips
- Drug Images
- Drug Interactions
- Compare Alternatives
- Pricing & Coupons
- 430 Reviews
- Drug class: 5HT3 receptor antagonists
Patient resources
- Drug Information
- Ondansetron injection
- Ondansetron Oral, Injection, Intravenous (Advanced Reading)
- Ondansetron Oral, Oromucosal (Advanced Reading)
- Ondansetron Orally Disintegrating Tablets
- Other brands
- Zofran, Zofran ODT, Zuplenz
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.